Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

July 8, 2008

And yet, another filler? Is this the Holy Grail?

This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Alan Zaccaria, MD, Plastic SurgeonAlan Zaccaria, MD
Plastic Surgeon, Alan Zaccaria, MD, FACS
Implications: Over the past few years, noninvasive cosmetic procedures have skyrocketed.  Soft tissue injectable fillers are among those procedures that are rapidly growing.  Up until now, hyaluronic acid (HA) fillers have been the mainstay.  With the emergence of Envolence, we have a new twist on an old product--collagen.  Since this does not involve skin testing and can be used at the same time as the patient's initial visit, this may prove to be an exciting new product, and may capture a fair share of the injectable filler market place.

Analysis:  Just when we thought we have seen every type of soft tissue filler, a new one, Envolence, hits the market.  This is not your father's filler, this is a new twist on an old theme, collagen.  The most popular fillers today are the hyaluronic acid (HA) fillers, and includes products such as Restylane and Juvederm.  These products are easy to use, are reliable, and last about 6 months.  Envolence was FDA approved for filling nasolabial folds, and was compared head to head with HA.  It lasted as long as the HA fillers, but has the advantage of being a collagen filler, and therefore does not maintain its effect by the absorption of water into the injection site as HA does.  It does not require skin testing, even though the older collagen products did.  It is dispensed in 1 cc syringes, but needs to be administered using a 27 gauge needle (slightly larger than the HA's, so potentially a bit more painful).  I am not sure about the cost comparisons, but if the price is comparable, I give it a big thumbs up.

Other Analyses of the Same Source Article:
Evolence: Will this New "Advanced" Collagen Filler Take Hold?
July 8, 2008, Author: Adam Schaffner, Plastic and Reconstructive Surgeon, The Detroit Medical Center
why are we going backwards
July 3, 2008, Author: GLG Expert Contributor
Canadian Experience with Evolence
July 2, 2008, Author: GLG Expert Contributor
Evolence Approval- what effect will it have on the filler market
July 2, 2008, Author: Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University
Concerns about Evolence being successful.
July 2, 2008, Author: GLG Expert Contributor

Report a Concern

GLG News: What Experts Think Is Important





Analytics